CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jan 13, 2012 · 10-Q · 44 days after period end · 0001303681-12-000006
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Income | -$10.25K | -$8.81K |
| EPS Diluted | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended Nov 30, 2011 · filed Jan 13, 2012 · 44 d after period end
